(Q41919910)

14 October 2017

Pharmacokinetic aspects of chloroquine-induced pruritus: influence of dose and evidence for varied extent of metabolism of the drug (English)

1 reference

14 October 2017

0 references

1 reference

Onyeji CO

1

1 reference

PubMed ID

11297904

14 October 2017

Ogunbona FA

series ordinal

2

1 reference

PubMed ID

11297904

14 October 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

European Journal of Pharmaceutical Sciences

14 October 2017

1 reference

14 October 2017

13

1 reference

14 October 2017

195-201

1 reference

14 October 2017

2

1 reference

Chloroquine-induced pruritus in malaria fever: contribution of malaria parasitaemia and the effects of prednisolone, niacin, and their combination, compared with antihistamine

14 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900108-7

7 January 2021

The disposition of chloroquine and its main metabolite desethylchloroquine in volunteers with and without chloroquine-induced pruritus: evidence for decreased chloroquine metabolism in volunteers with pruritus

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900108-7

7 January 2021

Stereoselective pharmacokinetic properties of chloroquine and de-ethyl-chloroquine in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900108-7

7 January 2021

Effect of chloroquine on histamine-induced bronchial asthma in the guinea-pig

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900108-7

7 January 2021

Interindividual variations in drug disposition. Clinical implications and methods of investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900108-7

7 January 2021

Defective oxidation of drugs: pharmacokinetic and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900108-7

7 January 2021

Chloroquine disposition in hypersensitive and non-hypersensitive subjects and its significance in chloroquine-induced pruritus

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900108-7

7 January 2021

Polymorphic drug oxidation: pharmacokinetic basis and comparison of experimental indices

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900108-7

7 January 2021

Liquid chromatographic analysis of chloroquine and desethylchloroquine in human plasma, saliva and urine

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900108-7

7 January 2021

Onset of pruritogenicity of chloroquine and the implication for the timing of suppressive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900108-7

7 January 2021

Chloroquine-induced pruritus and sickle cell gene trait in Africans: possible pharmacogenetic relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900108-7

7 January 2021

Mechanisms of chloroquine-induced body-scratching behavior in rats: evidence of involvement of endogenous opioid peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900108-7

7 January 2021

Lack of pharmacokinetic interaction between chloroquine and imipramine.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900108-7

7 January 2021

Chloroquine-associated pruritus in a European

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900108-7

7 January 2021

Enhanced efficacy of chloroquine-chlorpheniramine combination in acute uncomplicated falciparum malaria in children

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2801%2900108-7

7 January 2021

10.1016/S0928-0987(01)00108-7

Identifiers

DOI

1 reference

14 October 2017

1 reference

PubMed ID

11297904